Smith & Nephew plc SNN

Full chart Compare
Set alert

Price alert · SNN

All alert types
30.17 USD -0.07 (-0.23%)

At closeNov 3, 2026, 4:00 PM EST

30.17 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

30.05 Day range 30.38
26.12 52-week range 37.09
YTD
-8.05%
1 year
-17.95%
Market cap
12.63B
Revenue (ttm)
6.30B
Profit margin
10.08%
EPS (ttm)
1.47
Shares out
418.52M
P/E ratio
20.52
Forward P/E
12.54
Dividend
0.79 (2.63%)
Ex-dividend date
Oct 1, 2026
YTD return
-8.05%
1-year return
-17.95%
Volume
2.54M
Avg volume
1.46M
Open
30.29
Previous close
30.24
Day's range
30.05 – 30.38
52-week range
26.12 – 37.09
Beta
0.67
Price target
32.32 (+7.1%)
Earnings date
Feb 23, 2027

2Y +4.90 (+19.38%)

253035Jan 25Jun 25Nov 25Mar 26Aug 2630.18

Key statistics

Enterprise value
67.38B
PEG ratio
1.18
Price / sales
2.01
Price / book
12.41
Dividend yield
2.63%
Payout ratio
53.20%
Revenue growth
4.60%
Free cash flow
1.06B
Total cash
754.00M
Total debt
3.78B
Return on equity
11.85%
Short % of float
0.97%
50-day average
28.33
200-day average
31.05

Financials — quick view

All financials
SNN Revenue — annual 6.16B
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025
SNN Net income — annual 625.00M
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025
SNN EPS — annual 1.44
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025

Earnings

SNN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 27, 20261.21———
Aug 4, 2026Jun 27, 20260.9390.946+0.01+0.75%
Mar 2, 2026Dec 31, 20251.161.18+0.02+1.72%
Aug 5, 2025Jun 30, 20250.790.858+0.07+8.61%
Feb 25, 2025Dec 31, 20240.920.938+0.02+1.96%
Oct 31, 2024Jun 29, 20240.800.50-0.30-37.50%

Upgrades / downgrades

SNN analyst upgrades and downgrades
DateFirmActionFromTo
Aug 31, 2026BTIGinit—Neutral
Aug 6, 2026JP MorgandownOverweightNeutral
Aug 5, 2026BarclaysdownEqual-WeightUnderweight
May 11, 2026Canaccord GenuitymainHoldHold
Mar 5, 2026Canaccord GenuitymainHoldHold
Nov 11, 2025Canaccord GenuitymainHoldHold

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Sector
Healthcare
Industry
Medical Devices
Country
United Kingdom

News

Your note

Sign in to keep a note on SNN — it syncs with the Stock Master app.

Insider holders

SNN insider holders
InsiderRelationLatest transactionDateShares held
Bank Of America Securities Llc—HoldingJul 19, 202610,038,466
BlackRock Investment Management (UK) Ltd.—DecreaseNov 13, 2025433,611
Connolly (Paul)—BoughtJul 9, 20262,833
Dhankhar (Ajay)—BoughtNov 5, 202518,460
King (David)—BoughtAug 18, 20252,800
Kong (Garheng)—BoughtNov 5, 20253,000

Institution ownership

SNN institution ownership
Holder% heldSharesValueReported
River Road Asset Management, LLC0.77%3,221,87697.30MJun 29, 2026
Goldman Sachs Group Inc0.73%3,069,59892.70MJun 29, 2026
Brandes Investment Partners L.P.0.51%2,148,73164.89MJun 29, 2026
Dimensional Fund Advisors LP0.44%1,837,26155.49MJun 29, 2026
LMR Partners LLP0.42%1,767,87253.39MJun 29, 2026
Causeway Capital Management LLC0.37%1,565,16747.27MJun 29, 2026

Fund ownership

SNN fund ownership
Holder% heldSharesValueReported
Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd.0.08%333,42810.07MAug 30, 2026
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.0.07%273,6388.26MJul 30, 2026
Dimensional ETF Trust-Dimensional International Core Equity 2 ETF0.07%297,6618.99MJul 30, 2026
American Century ETF Trust-Avantis International Equity ETF0.07%272,4208.23MSep 29, 2026
2023 ETF Series Trust-Brandes International ETF0.06%256,4047.74MJun 29, 2026
JNL Series Trust-JNL MULTI-MANAGER SMALL CAP VALUE FUND0.05%201,1476.07MJun 29, 2026